YOUR COMPREHENSIVE MEDICAL
DEVICE INNOVATION PARTNER

OUR SERVICES

Regulatory
Services

Assessment and regulatory filing in the USA, Europe, and Canada.

Quality
Management

International standards, including ISO 13485, CMDCAS, and FDA QSR.

Product
Development

Turnkey product development from R&D to commercialization.

Clinical Trial
Services

All phases of feasibility and methodology design.

Due Diligence
& Market Appraisals

Projects including wearables, medical device, and health technology.

Revolutionize Medical TechnologyWe help visionaries bring their projects to life.

ABOUT US

Ironstone Product Development (IPD) assists its clients with all aspects of medical device and health product development and commercialization. Our team members have successfully commercialized dozens of innovative medical and healthcare products.

These products have changed the practice of healthcare and have generated transformative revenue for the companies involved. We work with entrepreneurs and established companies to help define the right product and find the most efficient way to get it in the hands of the clinicians and patients that need it.

REGULATORY SERVICES

We cover everything from pre-submission and classification of your product (Class II vs. De-Novo vs. Class III), to regulatory submissions. We have drafted dozens of successful submissions across several therapeutic areas.

Our services include technical file and design dossier preparation, clinical evaluations, and post market surveillance to meet all European regulations.

Canada is an excellent location to conduct clinical studies, ranging from first-in-man to multi-center pivotal trials. We can take your project through pre-submission engagement, to Investigational Testing Authorization (ITA) preparation, to licence applications (Class II-IV).

REQUEST A CALL BACK.

Would you like to speak to one of our consultants about your project? If you send us your contact details then we’ll be in touch shortly. You can also contact us directly if you prefer.

I would like to discuss: